17 June 2024 - Immunotherapy company Northwest Biotherapeutics (OTCQB: NWBO) announced on Monday that it has secured an exclusive license from Roswell Park Comprehensive Cancer Center for a portfolio of dendritic cell technologies and intellectual pr...
17 June 2024 - Alternative asset management firm TPG (NASDAQ: TPG) declared on Monday that it has made a strategic investment in K2 Medical Research, an integrated clinical trial site platform specialising in central nervous system trials.Founded by ...
17 June 2024 - Eye health company Bausch + Lomb Corporation (NYSE: BLCO) (TSX: BLCO) announced on Wednesday that it will present new scientific data and host educational events at the European Dry Eye Society (EuDEC) 2024 Congress in Madrid, Spain, f...
17 June 2024 - Immunotherapy company Innate Pharma SA (Euronext Paris: IPH) (Nasdaq: IPHA) on Monday announced updated results from the Phase 1/2 trial of SAR443579/IPH6101 (SAR'579), a first-in-class NK cell engager targeting CD123.Developed un...
17 June 2024 - Biopharmaceutical company HUTCHMED (China) Limited (Nasdaq: HCM) (AIM: HCM) (HKEX: 13) announced on Monday that results from its Phase III trial ESLIM-01 of sovleplenib (HMPL-523) for primary immune thrombocytopenia (ITP) have been pub...